FindTrial
Sign In

Role of assessing microbiome with colonoscopic lavage in patients with inflammatroy bowel disease

Role of assessing microbiome with colonoscopic lavage in patients with inflammatroy bowel disease

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003352
Enrollment
30
Registered
2018-11-16
Start date
2018-10-22
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

CHUNLAB
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 10 Healthy patients without special underlying disease 10 Crohn's disease 10 Ulcerative colitis

Exclusion criteria

Exclusion criteria: Follow up loss patients Adverse event during test

Design outcomes

Primary

MeasureTime frame
to investigate the differences in the sampling methods of each of the three sampling methods: aspiration through the colonoscopy, endoscopic biopsy, and fecal sampling—

Secondary

MeasureTime frame
any difference in intestinal flushing fluid in patients with inflammatory bowel disease compared with healthy persons.—

Countries

Korea, Republic of

Contacts

Public ContactLee Sub

Myongji Hospital

epoch0123@naver.com+82-31-810-5114

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 14, 2026